Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Acute Pancreatitis II: Clinical Manifestations and Management

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Neurogenic diarrhoea after superior mesenteric artery divestment or resection for pancreatic adenocarcinoma following preoperative chemotherapy: international multicentre retrospective study.

BJS open·2026

Same author

Impact of preoperative radiotherapy on the risk of postpancreatectomy haemorrhage and major morbidity after resection of pancreatic adenocarcinoma including arterial divestment or arterial resection.

BJS open·2026

Same author

Postpancreatectomy liver injury: A relevant entity in the modern era of pancreatic cancer surgery with hepatic vessel resection. A monocentric retrospective cohort study.

Surgery·2026

Same author

Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic multicenter development and validation of prognostic models.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2026

Same author

ASO Author Reflections: Decision Analysis in the Era of Evolving Guidelines for Branch-Duct IPMN.

Annals of surgical oncology·2026

Same author

Histotripsy for liver tumours: a systematic review and meta-analysis of current clinical evidence.

EClinicalMedicine·2026

Search research articles

Related Experiment Video

Updated: Jun 25, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

Quantifying Patient Risk Threshold in Managing Pancreatic Intraductal Papillary Mucinous Neoplasms.

Sarah R Kaslow¹, Acacia R Sharma¹, D Brock Hewitt¹

¹Department of Surgery, NYU Langone Health, New York, NY.

Annals of Surgery

|May 29, 2024

Summary

This summary is machine-generated.

Patient preferences for intraductal papillary mucinous neoplasms (IPMNs) vary. Understanding individual cancer risk thresholds and anxiety levels is crucial for shared decision-making in IPMN management.

Keywords:

decision making intraductal papillary mucinous neoplasms risk threshold

More Related Videos

Management of the Uncinate Process in No-Touch Laparoscopic Pancreaticoduodenectomy

Management of the Uncinate Process in No-Touch Laparoscopic Pancreaticoduodenectomy

Published on: May 5, 2023

Technical Detail for Robot Assisted Pancreaticoduodenectomy

Technical Detail for Robot Assisted Pancreaticoduodenectomy

Published on: September 28, 2019

Related Experiment Videos

Last Updated: Jun 25, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

Management of the Uncinate Process in No-Touch Laparoscopic Pancreaticoduodenectomy

Management of the Uncinate Process in No-Touch Laparoscopic Pancreaticoduodenectomy

Published on: May 5, 2023

Technical Detail for Robot Assisted Pancreaticoduodenectomy

Technical Detail for Robot Assisted Pancreaticoduodenectomy

Published on: September 28, 2019

Area of Science:

Gastroenterology
Surgical Oncology
Medical Decision Making

Background:

Management of intraductal papillary mucinous neoplasms (IPMNs) is complex.
Aligning treatment decisions with patient preferences is an area for improvement.

Purpose of the Study:

To understand patient treatment preferences for incidentally identified IPMNs.
To quantify the cancer risk threshold at which preferences shift.
To inform patient counseling and shared decision-making.

Main Methods:

Survey of 520 healthy volunteers simulating incidental IPMN diagnosis.
Assessed treatment preference (surgery vs. surveillance) at 5% cancer risk.
Quantified individual cancer risk thresholds for treatment change.
Measured cancer anxiety using a 5-point Likert scale.
Used multivariable linear regression to analyze associations.

Main Results:

Median risk threshold was 25%, with a bimodal distribution.
At 5% risk, 62% preferred surveillance, 38% preferred surgery.
Higher cancer anxiety correlated with significantly lower risk thresholds.

Conclusions:

Significant variability exists in IPMN treatment preferences and risk thresholds.
Patient anxiety about malignancy influences their risk threshold.
Understanding patient-specific risk thresholds is key for shared decision-making in IPMN management.